Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanders, D.
Right arrow Articles by Buckley, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanders, D.
Right arrow Articles by Buckley, E.

NEUROLOGY 1986;36:545-547
© 1986 American Academy of Neurology

ARTICLES

Botulinum toxin for blepharospasm: single-fiber EMG studies

DB Sanders, EW Massey and EG Buckley

In four patients who received periocular injections of botulinum toxin for blepharospasm, abnormal neuromuscular transmission was demonstrated by single-fiber EMG in arm muscles. The time course with which the abnormalities developed and cleared, as well as the inverse relationship between the neuromuscular jitter and the firing rate in the abnormal muscles, indicated that the toxin caused the abnormalities in arm muscles. No weakness was detected clinically in muscles distant from the face, but the abnormal neuromuscular transmission indicates that the toxin spread remotely from the site of injection.


This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J C Morgan, S S Iyer, E T Moser, C Singer, and K D Sethi
Botulinum toxin A during pregnancy: a survey of treating physicians
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 117 - 119.
[Abstract] [Full Text] [PDF]

Home page
 Arch Facial Plast SurgHome page
A. Blitzer and W. J. Binder
Cosmetic Uses of Botulinum Neurotoxin Type A: An Overview
Arch Facial Plast Surg, October 1, 2002; 4(4): 214 - 220.
[Full Text] [PDF]

Home page
 Arch Facial Plast SurgHome page
I. D. Papel and R. B. Capone
Botulinum Toxin A for Mentalis Muscle Dysfunction
Arch Facial Plast Surg, October 1, 2001; 3(4): 268 - 269.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
K P Bhatia, A Münchau, P D Thompson, M Houser, V S Chauhan, M Hutchinson, A H V Shapira, and C D Marsden
Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases
J. Neurol. Neurosurg. Psychiatry, July 1, 1999; 67(1): 90 - 93.
[Abstract] [Full Text]

Home page
 J Child NeurolHome page
L. A. Koman, J. F. Mooney III, and B. P. Smith
Neuromuscular Blockade in the Management of Cerebral Palsy
J Child Neurol, November 1, 1996; 11(1_suppl): S23 - S28.
[Abstract] [PDF]

Home page
 Arch OphthalmolHome page
J. D. Porter, S. Strebeck, and N. F. Capra
Botulinum-Induced Changes in Monkey Eyelid Muscle: Comparison With Changes Seen in Extraocular Muscle
Arch Ophthalmol, March 1, 1991; 109(3): 396 - 404.
[Abstract] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
D. B. SANDERS and J. M. MASSEY
Management of Facial Spasm With Clostridium botulinum Toxin
Arch Otolaryngol Head Neck Surg, July 1, 1989; 115(7): 882 - 882.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.